Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enteral Tranexamic Acid in Critically Ill Patients
NCT01683747Phase 2Terminated
- Sponsor
- VA San Diego Healthcare System
- Start
- Jun 2012
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tranexamic acid in critical illness, Shock, sponsored by VA San Diego Healthcare System. Started Jun 2012; status: terminated.
02
Drugs
tranexamic acid
03
Conditions
critical illnessShock
Beyond the preview
Go deeper on NCT01683747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01683747.